ACTIVE

PHARMACIE MERTENS

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result149 k €-27,4 %over 1 year
Gross margin319,4 k €-9,0 %over 1 year
Equity490,6 k €+4,0 %over 1 year
Workforce1,5 ETP+25,0 %over 1 year

Identity

Source · BCE/KBO

PHARMACIE MERTENS is a Private company with limited liability incorporated in 1990. Its registered office is in Celles (lez-Tournai). It employs on average 1,5 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0442.845.481
Incorporation
28/12/1990
Legal form
Private company with limited liability
Registered office
Rue Monseigneur Descamps 18
7760 Celles (lez-Tournai) · WallonieSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2025
Average workforce
1,5 ETP
Joint committees (2)
  • 313
  • 31300
Signals
ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 21 filings

Trend over 20 financial years

20252024202320222021
Income statement
Gross margin319,4 k €351,1 k €312,1 k €315,9 k €320 k €
EBITDA249,2 k €299,4 k €262,9 k €266,1 k €234,1 k €
Operating result174,2 k €221,7 k €191,2 k €204,9 k €167,5 k €
Net result149 k €205,3 k €164,4 k €178,2 k €141,6 k €
Balance sheet
Equity490,6 k €471,6 k €446,3 k €431,9 k €403,7 k €
Total assets1,7 M €1,7 M €1,6 M €1,6 M €1,3 M €
Cash87,1 k €101,9 k €130,5 k €204,9 k €115,4 k €
Debts1,2 M €1,2 M €1,2 M €1,1 M €904,9 k €
Other
Workforce1,5 ETP1,2 ETP1,2 ETP1,3 ETP2,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 6 ended

Active mandates

ESCAPHARM

Director · 0897.206.151

Represented by Renaud Mertens

Active

Ended mandates

ESCAPHARM

Director · since 01 octobre 2009 · 0897.206.151

Represented by Mertens RENAUD

Ended
ESCAPHARM

Manager · since 01 octobre 2009 · 0897.206.151

Represented by RENAUD MERTENS

Ended
ESCAPHARM

Director · since 01 octobre 2009 · 0897.206.151

Represented by Mertens RENAUD

Ended
ESCAPHARM

Director · since 01 octobre 2009 · 0897.206.151

Represented by RENAUD MERTENS

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date13/08/202621/08/202522/08/202424/08/202325/08/202225/06/2021
General meeting03/08/202607/06/202501/06/202403/06/202304/06/202205/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 21 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202503/08/202613/08/2026FrenchPDF
Abridged modelCorrection31/12/202407/06/202521/08/2025FrenchPDF
Abridged model31/12/202407/06/202518/07/2025FrenchPDF
Abridged model31/12/202301/06/202422/08/2024FrenchPDF
Abridged model31/12/202203/06/202324/08/2023FrenchPDF
Abridged model31/12/202104/06/202225/08/2022FrenchPDF
Abridged model31/12/202005/06/202125/06/2021FrenchPDF
Abridged model31/12/201906/06/202024/08/2020FrenchPDF
Abridged model31/12/201801/06/201927/06/2019FrenchPDF
Abridged model31/12/201702/06/201828/06/2018FrenchPDF
Abridged model31/12/201603/06/201728/07/2017FrenchPDF
Abridged model31/12/201504/06/201604/07/2016FrenchPDF
Abridged model31/12/201406/06/201523/06/2015FrenchPDF
Abridged model31/12/201307/06/201403/07/2014FrenchPDF
Abridged model31/12/201201/06/201327/06/2013FrenchPDF
Abridged model31/12/201102/06/201225/07/2012FrenchPDF
Abridged model31/12/201004/06/201130/06/2011FrenchPDF
Abridged model31/12/200905/06/201027/07/2010DutchPDF
Abridged model31/12/200806/06/200925/06/2009FrenchPDF
Abridged model31/12/200708/08/200830/08/2008DutchPDF
Abridged model31/12/200608/08/200713/09/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 6 ended

Active mandates

ESCAPHARM

Director · 0897.206.151

Represented by Renaud Mertens

Active

Ended mandates

ESCAPHARM

Director · since 01 octobre 2009 · 0897.206.151

Represented by Mertens RENAUD

Ended
ESCAPHARM

Manager · since 01 octobre 2009 · 0897.206.151

Represented by RENAUD MERTENS

Ended
ESCAPHARM

Director · since 01 octobre 2009 · 0897.206.151

Represented by Mertens RENAUD

Ended
ESCAPHARM

Director · since 01 octobre 2009 · 0897.206.151

Represented by RENAUD MERTENS

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates18/11/2009
    DENOMINATION - DEMISSIONS, NOMINATIONS
    PDF
  • Registered office05/01/2006
    SIEGE SOCIAL - CAPITAL, ACTIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025149 k €↓
  2. 2024
    Annual accounts 2024205,3 k €↑
  3. 2023
    Annual accounts 2023164,4 k €↓
  4. 2022
    Annual accounts 2022178,2 k €↑
  5. 2021
    Annual accounts 2021141,6 k €↓
  6. 2020
    Annual accounts 2020154,5 k €↑
  7. 2019
    Annual accounts 2019127,7 k €↑
  8. 2018
    Annual accounts 201817,7 k €↑
  9. 2017
    Annual accounts 20171,5 k €↑
  10. 2016
    Annual accounts 20161,3 k €↓
  11. 2015
    Annual accounts 20152,2 k €↓
  12. 2014
    Annual accounts 201414 k €↑
  13. 2013
    Annual accounts 201310,9 k €↓
  14. 2012
    Annual accounts 201221,9 k €↓
  15. 2011
    Annual accounts 201127,6 k €↑
  16. 2010
    Annual accounts 201013,1 k €↑
  17. 2009
    Annual accounts 2009-14,7 k €↓
  18. 2008
    Annual accounts 200814,8 k €↓
  19. 2007
    Annual accounts 200723,1 k €↑
  20. 2006
    Annual accounts 2006-2,5 k €
  21. 28/12/1990
    IncorporationPrivate company with limited liability